Thyrocare Technologies shares pledged for API Holdings debentures

Docon Technologies Private Limited has pledged 6,46,46,464 bonus shares of Thyrocare Technologies Ltd in favor of Catalyst Trusteeship Limited. This pledge, executed on December 2, 2025, serves as security for the obligations of API Holdings Limited related to its secured, unlisted, redeemable non-convertible debentures.

Prior to this transaction, encumbered shares stood at 3,23,23,232, representing 20.31% of the total share/voting capital. Post-acquisition, the number of encumbered shares has increased to 6,46,46,464, now accounting for 40.62% of Thyrocare's total share/voting capital. The total equity share capital of Thyrocare Technologies is 15,91,61,691 equity shares of ₹10 each.

The disclosure, filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, highlights a change in the equity shares pledged, specifically due to the issuance of bonus shares by Thyrocare Technologies. The transaction was facilitated by Deesha Srikkanth, senior vice president of Catalyst Trusteeship Limited.